Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy

The application of nanoparticle drug formulations, such as nanoliposomal doxorubicin (Doxil), is increasingly integrated in clinical cancer care. Despite nanomedicine's remarkable potential and growth over the last three decades, its clinical benefits for cancer patients vary. Here we report a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nat Commun
Asıl Yazarlar: Pérez-Medina, Carlos, Abdel-Atti, Dalya, Tang, Jun, Zhao, Yiming, Fayad, Zahi A., Lewis, Jason S., Mulder, Willem J. M., Reiner, Thomas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4915130/
https://ncbi.nlm.nih.gov/pubmed/27319780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms11838
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller